Table 2. HPV prevalence among women from the CARE Project and the NHANES.
CARE – All women | CARE – Controls | CARE – Cases | NHANESa | |
(n = 1116) | (n = 838) | (n = 278) | ||
Any HPV | 43.1 (40.2–46.0) | 32.1 (28.9–35.3) | 76.3 (71.3–81.3) | 39.2 (37.0–41.4) |
High-risk HPVb | 33.5 (30.7–36.3) | 21.5 (18.7–24.3) | 69.8 (64.4–75.2) | 26.9 (24.7–29.1) |
Low-risk HPVc | 23.4 (20.9–25.9) | 17.4 (14.8–20.0) | 41.4 (35.6–47.2) | 26.1 (24.0–28.2) |
Note. Table reports percents and 95% confidence intervals in parentheses. HPV = human papillomavirus, CARE = Community Awareness Resources Education, NHANES = National Health and Nutrition Examination Survey.
Estimates from the NHANES are for non-Hispanic white women [4], since 93.9% of women from the CARE Project were non-Hispanic white.
Included HPV types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 64, 66, 67, 68, 69, 70, 73, 82, and IS39 [4].
Included HPV types 6, 11, 40, 42, 54, 55, 61, 62, 71, 72, 81, 83, 84, and 89 [4].